John Winkelman, MD PhD is theChief of theSleep Disorders Clinical Research Programin the Department of Psychiatry at Mass General and Professor of Psychiatry at Harvard Medical School. Dr. Winkelman's research has primarily focused in two areas: 1) epidemiology, physiology, cardiovascular consequences and treatment of restless legs syndrome, and 2) neurobiology and treatment of insomnia.
-
This update from the American Academy of Sleep Medicine presents a significant change in recommendations for the treatment of RLS, discouraging the use of commonly […] -
Informed by the work of J. Stuart Ablon, PhD and Think:Kids, this websIte offers resources to help families navigate difficult conversations about social media. -
A new website offers curbside consultations and evidence-based guidance to healthcare providers treating patients with RLS.
-
Outside of the benzodiazepines, there are several classes of pharmacological agents that may prove to be useful, including sedating antidepressants, dopaminergic antagonists, anticonvulsants, melatonin agonists. -
John Winkelman, MD, PhD, Chief of the Sleep Disorders Clinical Research Program in Psychiatry, has received the 2020 Ekbom Award from the Restless Legs Syndrome (RLS) […] -
Sleep disruption has been a common complaint during the pandemic. Uncertainty about the future and worries about the health and safety of loved ones fuel […]